JP Stock MarketDetailed Quotes

4883 Modalis Therapeutics

Watchlist
  • 141
  • +8+6.02%
20min DelayMarket Closed Nov 22 15:30 JST
8.32BMarket Cap-1825P/E (Static)

Modalis Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Modalis Therapeutics FY2024 9-Month Earnings Date

Currency：JPYNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
NI to Common Holders
--
-1.06B
--
+32.99%
Analyst Rating
No Data

Modalis Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20232023/Q20.000 / 0.000--
Feb 13, 20232022/Q40.000 / 800.000M--
Nov 7, 20222022/Q30.000 / 0.000--
Aug 5, 20222022/Q20.000 / 0.000--
May 9, 20222022/Q140.000M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20232023/Q20.000 / 0.000--
Feb 13, 20232022/Q40.000 / 800.000M--
Nov 7, 20222022/Q30.000 / 0.000--
Aug 5, 20222022/Q20.000 / 0.000--
May 9, 20222022/Q140.000M / 0.000--

Unlock Free Earnings Estimates

Modalis Therapeutics Earnings Reports

  • Modalis Therapeutics: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/12

    Nov 7 01:00 ET

  • Modalis Therapeutics: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)

    Nov 7 01:00 ET

  • Modalis Therapeutics: Confirmatory letter.

    Aug 13 01:58 ET

  • Modalis Therapeutics: Half Year Report - Term 9 (2024/01/01 - 2024/12/31)

    Aug 13 01:58 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data